From Laboratory to Patient: The Evolving Path to Become a Medicine

Gene editing and other laboratory developments promise to revolutionize treatment of many diseases that currently have no cure. The process to become a medicine is long and complex and requires many years. Regulation of medicines (permission to market a product and monitoring of its performance) is...

Full description

Bibliographic Details
Main Author: Ana Hidalgo-Simon
Format: Article
Language:English
Published: World Scientific Publishing 2019-12-01
Series:Molecular Frontiers Journal
Subjects:
Online Access:http://www.worldscientific.com/doi/pdf/10.1142/S2529732519400121
_version_ 1811266967593549824
author Ana Hidalgo-Simon
author_facet Ana Hidalgo-Simon
author_sort Ana Hidalgo-Simon
collection DOAJ
description Gene editing and other laboratory developments promise to revolutionize treatment of many diseases that currently have no cure. The process to become a medicine is long and complex and requires many years. Regulation of medicines (permission to market a product and monitoring of its performance) is evolving to adapt to emerging new approaches in development. Current issues and new ideas needed to navigate the difficult waters from laboratory to patient are discussed here: novel approaches for narrow evidence base, earlier discussions of evidence with regulators, earlier planning for post-authorization requirements and better patient access.
first_indexed 2024-04-12T20:53:52Z
format Article
id doaj.art-c4cb467c1fa74f6aa94f2bf1007ad674
institution Directory Open Access Journal
issn 2529-7325
2529-7333
language English
last_indexed 2024-04-12T20:53:52Z
publishDate 2019-12-01
publisher World Scientific Publishing
record_format Article
series Molecular Frontiers Journal
spelling doaj.art-c4cb467c1fa74f6aa94f2bf1007ad6742022-12-22T03:17:03ZengWorld Scientific PublishingMolecular Frontiers Journal2529-73252529-73332019-12-013213814610.1142/S252973251940012110.1142/S2529732519400121From Laboratory to Patient: The Evolving Path to Become a MedicineAna Hidalgo-SimonGene editing and other laboratory developments promise to revolutionize treatment of many diseases that currently have no cure. The process to become a medicine is long and complex and requires many years. Regulation of medicines (permission to market a product and monitoring of its performance) is evolving to adapt to emerging new approaches in development. Current issues and new ideas needed to navigate the difficult waters from laboratory to patient are discussed here: novel approaches for narrow evidence base, earlier discussions of evidence with regulators, earlier planning for post-authorization requirements and better patient access.http://www.worldscientific.com/doi/pdf/10.1142/S2529732519400121advanced therapyregenerative medicinegene therapysomatic cell therapytissue engineeringmedicine regulationregulatory agencieseuropean medicines agency (ema)
spellingShingle Ana Hidalgo-Simon
From Laboratory to Patient: The Evolving Path to Become a Medicine
Molecular Frontiers Journal
advanced therapy
regenerative medicine
gene therapy
somatic cell therapy
tissue engineering
medicine regulation
regulatory agencies
european medicines agency (ema)
title From Laboratory to Patient: The Evolving Path to Become a Medicine
title_full From Laboratory to Patient: The Evolving Path to Become a Medicine
title_fullStr From Laboratory to Patient: The Evolving Path to Become a Medicine
title_full_unstemmed From Laboratory to Patient: The Evolving Path to Become a Medicine
title_short From Laboratory to Patient: The Evolving Path to Become a Medicine
title_sort from laboratory to patient the evolving path to become a medicine
topic advanced therapy
regenerative medicine
gene therapy
somatic cell therapy
tissue engineering
medicine regulation
regulatory agencies
european medicines agency (ema)
url http://www.worldscientific.com/doi/pdf/10.1142/S2529732519400121
work_keys_str_mv AT anahidalgosimon fromlaboratorytopatienttheevolvingpathtobecomeamedicine